MPMC’s new initiative, Toward Pharmacogenomics-Enabled Healthcare at Statewide Scale: Implementing Precision Medicine, is among the six interdisciplinary projects selected to receive Grand Challenges Research Interdisciplinary Team Awards, Executive Vice President and Provost Karen Hanson announced on December 21, 2018. This is the third round of UMN Driving Tomorrow research investments for interdisciplinary collaborations aligned with goals of the campus strategic plan.
Read the Provost's announcement here.
MPMC will receive a two-year, $325,000 award to facilitate its project, led by principal investigators Constantin Aliferis, Pamala Jacobson, Catherine McCarty, and Susan M. Wolf.
As in the first two phases of the Grand Challenges Research Initiative, Phase 3 interdisciplinary team awards are an investment in high-quality research projects that will distinguish the University and its scholars as leaders in addressing Grand Challenges. MPMC’s new project deliberately focuses on one of the most mature domains of precision medicine, pharmacogenomics, which despite its proven scientific basis and immense promise has not yet been widely implemented in healthcare systems.
